You are here: Industry Insights > Biogen

News List

Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis drugs
December 26, 2018
Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) today announced that Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ....
Alkermes/Biogen hope for less tummy trouble with new MS pill pharmaphorum
December 19, 2018
Alkermes and Biogen have filed a new multiple sclerosis pill with the FDA, which they hope will treat the disease with fewer unpleasant gastrointestinal side effects than the big pharma’s older MS drug, Tecfidera.
Alkermes and Biogen announce new MS drug application for FDA pharmatimes
December 19, 2018
Alkermes and Biogen have announced that Alkermes has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for diroximel fumarate.
Alkermes, Biogen Submits NDA for Diroximel Fumarate americanpharmaceuticalreview
December 18, 2018
Alkermes and Biogen announced Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for diroximel fumarate (BIIB098).....
Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment for a Subtype of ALS americanpharmaceuticalreview
December 10, 2018
Biogen Inc and Ionis Pharmaceuticals, Inc. have announced that Biogen exercised its option to obtain from Ionis a worldwide, exclusive, royalty-bearing license to.....
Samsung BioLogics strikes back, filing lawsuit over criminal penalties imposed by Korean regulators fiercepharma
December 06, 2018
Two weeks after South Korean financial regulators imposed a laundry list of penalties on Samsung BioLogics for alleged accounting missteps related to its Biogen-partnered joint venture, the company has launched a counterattack.
HitGen, Biogen initiate drug discovery collaboration pharmatimes
November 26, 2018
HitGen Ltd has announced that the company has entered into a drug discovery research collaboration with Biogen to identify novel small molecule leads for targets of interest.
HitGen and Biogen enter a DNA-Encoded Library-Based Drug Discovery Research Collaboration pharmafocusasia
November 26, 2018
HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Biogen to identify novel small molecule leads for targets...
Biogen and Amicus win UK Prix Galien awards for rare disease medicines pharmaceutical
November 21, 2018
Medicinal products selected as the UK Prix Galien Award finalists were for orphan conditions. Credit: DraconianRain.
UCB and Biogen's lupus drug falls short at Phase 2b pharmafile
October 25, 2018
The partnership of UCB and Biogen announced disappointing news, confirming that its experimental therapy dapirolizumab pegol (DZP) failed to meet its primary endpoint in the treatment...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page